120 related articles for article (PubMed ID: 36192516)
1. Challenges of secondary finding disclosure in genomic medicine in rare diseases: A nation-wide survey of Japanese facilities outsourcing comprehensive genetic testing.
Hiromoto K; Yamada T; Tsuchiya M; Kawame H; Nanba E; Goto Y; Kosugi S
J Hum Genet; 2023 Jan; 68(1):1-9. PubMed ID: 36192516
[TBL] [Abstract][Full Text] [Related]
2. Difficulties in disclosing secondary findings by facilities performing comprehensive germline genetic testing for rare diseases in Japan.
Hiromoto K; Yamada T; Tsuchiya M; Kawame H; Nanba E; Goto Y; Kosugi S
Congenit Anom (Kyoto); 2024 May; 64(3):116-124. PubMed ID: 38530047
[TBL] [Abstract][Full Text] [Related]
3. Physicians' perceptions of the factors influencing disclosure of secondary findings in tumour genomic profiling in Japan: a qualitative study.
Shimada S; Yamada T; Iwakuma M; Kosugi S
Eur J Hum Genet; 2022 Jan; 30(1):88-94. PubMed ID: 34400810
[TBL] [Abstract][Full Text] [Related]
4. Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients.
Horiuchi Y; Matsubayashi H; Kiyozumi Y; Nishimura S; Higashigawa S; Kado N; Nagashima T; Mizuguchi M; Ohnami S; Arai M; Urakami K; Kusuhara M; Yamaguchi K
Hum Genet; 2021 Feb; 140(2):321-331. PubMed ID: 32710294
[TBL] [Abstract][Full Text] [Related]
5. Online questionnaire on genetic testing for intractable diseases in Japan: response to and issues associated with the revised medical care act.
Adachi K; Satou K; Nanba E
J Hum Genet; 2021 Nov; 66(11):1043-1051. PubMed ID: 34059779
[TBL] [Abstract][Full Text] [Related]
6. Attitudes toward and current status of disclosure of secondary findings from next-generation sequencing: a nation-wide survey of clinical genetics professionals in Japan.
Tsuchiya M; Yamada T; Akaishi R; Hamanoue H; Hirasawa A; Hyodo M; Imoto I; Kosho T; Kurosawa K; Murakami H; Nakatani K; Nomura F; Sasaki A; Shimizu K; Tamai M; Umemura H; Watanabe A; Yoshida A; Yoshihashi H; Yotsumoto J; Kosugi S
J Hum Genet; 2020 Dec; 65(12):1045-1053. PubMed ID: 32661284
[TBL] [Abstract][Full Text] [Related]
7. Ethical values supporting the disclosure of incidental and secondary findings in clinical genomic testing: a qualitative study.
Saelaert M; Mertes H; Moerenhout T; De Baere E; Devisch I
BMC Med Ethics; 2020 Jan; 21(1):9. PubMed ID: 32000764
[TBL] [Abstract][Full Text] [Related]
8. Whether, when, how, and how much? General public's and cancer patients' views about the disclosure of genomic secondary findings.
Cléophat JE; Dorval M; El Haffaf Z; Chiquette J; Collins S; Malo B; Fradet V; Joly Y; Nabi H
BMC Med Genomics; 2021 Jun; 14(1):167. PubMed ID: 34174888
[TBL] [Abstract][Full Text] [Related]
9. A Scoping Review of Global Guidelines for the Disclosure of Secondary Genomic Findings to Inform the Establishment of Guidelines in China.
Jiang S
China CDC Wkly; 2022 Aug; 4(32):697-705. PubMed ID: 36060441
[TBL] [Abstract][Full Text] [Related]
10. Current status and issues related to secondary findings in the first public insurance covered tumor genomic profiling in Japan: multi-site questionnaire survey.
Minamoto A; Yamada T; Shimada S; Kinoshita I; Aoki Y; Oda K; Ueki A; Higashigawa S; Morikawa M; Sato Y; Hirasawa A; Ogawa M; Kondo T; Yoshioka M; Kanai M; Muto M; Kosugi S
J Hum Genet; 2022 Oct; 67(10):557-563. PubMed ID: 35322199
[TBL] [Abstract][Full Text] [Related]
11. An spanish study of secondary findings in families affected with mendelian disorders: choices, prevalence and family history.
Codina-Solà M; Trujillano L; Abulí A; Rovira-Moreno E; Muñoz-Cabello P; Campos B; Fernández-Álvarez P; Palau D; Carrasco E; Valenzuela I; Cueto-González AM; Lasa-Aranzasti A; Limeres J; Leno-Colorado J; Costa-Roger M; Moles-Fernández A; Balmaña J; Díez O; Cuscó I; Garcia-Arumí E; Tizzano EF
Eur J Hum Genet; 2023 Feb; 31(2):223-230. PubMed ID: 36446894
[TBL] [Abstract][Full Text] [Related]
12. A model for the return and referral of all clinically significant secondary findings of genomic sequencing.
Kodida R; Reble E; Clausen M; Shickh S; Mighton C; Sam J; Forster N; Panchal S; Aronson M; Semotiuk K; Graham T; Silberman Y; Randall Armel S; McCuaig JM; Cohn I; Morel CF; Elser C; Eisen A; Carroll JC; Glogowski E; Schrader KA; Di Gioacchino V; Lerner-Ellis J; Kim RH; Bombard Y;
J Med Genet; 2023 Aug; 60(8):733-739. PubMed ID: 37217257
[TBL] [Abstract][Full Text] [Related]
13. A systematic literature review of disclosure practices and reported outcomes for medically actionable genomic secondary findings.
Sapp JC; Facio FM; Cooper D; Lewis KL; Modlin E; van der Wees P; Biesecker LG
Genet Med; 2021 Dec; 23(12):2260-2269. PubMed ID: 34433902
[TBL] [Abstract][Full Text] [Related]
14. Frequency of genomic secondary findings among 21,915 eMERGE network participants.
eMERGE Clinical Annotation Working Group
Genet Med; 2020 Sep; 22(9):1470-1477. PubMed ID: 32546831
[TBL] [Abstract][Full Text] [Related]
15. Frequency of actionable secondary findings in 7472 Korean genomes derived from the National Project of Bio Big Data pilot study.
Kim Y; Kim JM; Cho HW; Park HY; Park MH
Hum Genet; 2023 Nov; 142(11):1561-1569. PubMed ID: 37728764
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations.
Pujol P; Vande Perre P; Faivre L; Sanlaville D; Corsini C; Baertschi B; Anahory M; Vaur D; Olschwang S; Soufir N; Bastide N; Amar S; Vintraud M; Ingster O; Richard S; Le Coz P; Spano JP; Caron O; Hammel P; Luporsi E; Toledano A; Rebillard X; Cambon-Thomsen A; Putois O; Rey JM; Hervé C; Zorn C; Baudry K; Galibert V; Gligorov J; Azria D; Bressac-de Paillerets B; Burnichon N; Spielmann M; Zarca D; Coupier I; Cussenot O; Gimenez-Roqueplo AP; Giraud S; Lapointe AS; Niccoli P; Raingeard I; Le Bidan M; Frebourg T; Rafii A; Geneviève D
Eur J Hum Genet; 2018 Dec; 26(12):1732-1742. PubMed ID: 30089825
[TBL] [Abstract][Full Text] [Related]
17. Genomic tools for health: Secondary findings as findings to be shared.
Miner SA; Similuk M; Jamal L; Sapp J; Berkman BE
Genet Med; 2022 Nov; 24(11):2220-2227. PubMed ID: 35980380
[TBL] [Abstract][Full Text] [Related]
18. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
[TBL] [Abstract][Full Text] [Related]
19. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
20. Beyond medically actionable results: an analytical pipeline for decreasing the burden of returning all clinically significant secondary findings.
Reble E; Gutierrez Salazar M; Zakoor KR; Khalouei S; Clausen M; Kodida R; Shickh S; Mighton C; Cohn I; Schrader KA; Kim RH; Lerner-Ellis J; Bombard Y
Hum Genet; 2021 Mar; 140(3):493-504. PubMed ID: 32892247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
